4.8 Editorial Material

Long-distance inflammatory and genotoxic impact of cancer in vivo

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1013093107

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram

Dusana Majera, Zdenek Skrott, Jan Bouchal, Jirina Bartkova, Dana Simkova, Mariam Gachechiladze, Jana Steigerova, Daniela Kurfurstova, Jan Gursky, Gabriela Korinkova, Karel Cwiertka, Zdenek Hodny, Martin Mistrik, Jiri Bartek

PROSTATE (2019)

Article Oncology

Senolytic Cocktail Dasatinib+Quercetin (D+Q) Does Not Enhance the Efficacy of Senescence-Inducing Chemotherapy in Liver Cancer

Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek, Manlio Vinciguerra

FRONTIERS IN ONCOLOGY (2018)

Article Genetics & Heredity

PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair

Marketa Vancurova, Hana Hanzlikova, Lucie Knoblochova, Jan Kosla, Dusana Majera, Martin Mistrik, Kamila Burdova, Zdenek Hodny, Jiri Bartek

DNA REPAIR (2019)

Article Biochemistry & Molecular Biology

Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase

Zdenek Skrott, Dusana Majera, Jan Gursky, Tereza Buchtova, Marian Hajduch, Martin Mistrik, Jiri Bartek

ONCOGENE (2019)

Article Cell Biology

Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway

Dusana Majera, Zdenek Skrott, Katarina Chroma, Joanna Maria Merchut-Maya, Martin Mistrik, Jiri Bartek

CELLS (2020)

Review Biochemistry & Molecular Biology

Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells

Dusana Majera, Martin Mistrik

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade

Alena Mickova, Gvantsa Kharaishvili, Daniela Kurfurstova, Mariam Gachechiladze, Milan Kral, Ondrej Vacek, Barbora Pokryvkova, Martin Mistrik, Karel Soucek, Jan Bouchal

Summary: The study found significantly increased expression of Skp2, AR, and Slug, as well as downregulation of E-cadherin in primary prostate cancer patients with lymph node metastases. The correlation between Skp2 and Slug and AR was enhanced in patients with high Gleason scores, indicating their potential importance in prostate cancer progression. Novel treatment strategies targeting Skp2 and Slug through neddylation blockade may hold promise for advanced prostate cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Microthermal-induced subcellular-targeted protein damage in cells on plasmonic nanosilver-modified surfaces evokes a two-phase HSP-p97/VCP response

Martin Mistrik, Zdenek Skrott, Petr Muller, Ales Panacek, Lucie Hochvaldova, Katarina Chroma, Tereza Buchtova, Veronika Vandova, Libor Kvitek, Jiri Bartek

Summary: The study introduces a method utilizing plasmonic silver nanoparticles to induce targeted thermal protein damage, allowing for the exploration of cellular stress-response pathways and offering potential therapeutic targets for degenerative diseases.

NATURE COMMUNICATIONS (2021)

Article Oncology

Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

Tereza Buchtova, Zdenek Skrott, Katarina Chroma, Jiri Rehulka, Petr Dzubak, Marian Hajduch, David Lukac, Stefanos Arampatzis, Jiri Bartek, Martin Mistrik

Summary: Disulfiram (DSF), a known alcohol-aversion drug, is being considered for repurposing in cancer treatment, but the presence of other drugs may interfere with its efficacy. Research has found that cannabidiol, a component of marijuana, could reduce the effectiveness of DSF in treating cancer, leading to inconsistent clinical outcomes.

MOLECULAR ONCOLOGY (2022)

Article Geriatrics & Gerontology

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects

Marco Raffaele, Kristina Kovacovicova, Tommaso Biagini, Oriana Lo Re, Jan Frohlich, Sebastiano Giallongo, James D. Nhan, Antonino Giulio Giannone, Daniela Cabibi, Martin Ivanov, Anton B. Tonchev, Martin Mistrik, Matthew Lacey, Petr Dzubak, Sona Gurska, Marian Hajduch, Jiri Bartek, Tommaso Mazza, Vincenzo Micale, Sean P. Curran, Manlio Vinciguerra

Summary: The study identified MCOPB as a NOP ligand with tissue-specific senolytic effects, reducing the senescent cell burden in peripheral tissues but not affecting the central nervous system. Additionally, exposure to MCOPB led to changes in locomotion and lipid storage. Mechanistically, MCOPB treatment activated transcriptional networks involved in immune responses to external stressors, implicating Toll-like receptors (TLRs).

GEROSCIENCE (2022)

Article Cell Biology

A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment

Katarina Chroma, Zdenek Skrott, Jan Gursky, Jaroslav Bacovsky, Pavel Moudry, Tereza Buchtova, Martin Mistrik, Jiri Bartek

Summary: Despite various therapeutic modalities, multiple myeloma remains incurable with low treatment success rate. The common treatment targeting proteasome often leads to drug resistance. In this study, the authors propose a novel proteasome-like inhibitor agent called CuET formed in vivo and in vitro from a known drug, disulfiram. They demonstrate the effectiveness of CuET in killing different resistant forms of multiple myeloma cells, including those resistant to common anti-myeloma drugs. Furthermore, CuET can overcome another form of treatment resistance based on reduced proteasome load. The findings suggest that repurposing disulfiram in combination with copper supplementation could offer a promising treatment option for relapsed and therapy-resistant multiple myeloma patients.

CELL DEATH & DISEASE (2022)

Article Pharmacology & Pharmacy

One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy

Radu A. Paun, Daciana C. Dumut, Amanda Centorame, Thusanth Thuraisingam, Marian Hajduch, Martin Mistrik, Petr Dzubak, Juan B. De Sanctis, Danuta Radzioch, Maryam Tabrizian

Summary: The study developed a stable and scalable formulation of CuET by encapsulating it in nanoliposomes, addressing the issues of poor solubility in water and low bioavailability. The formulation demonstrated excellent stability and controlled drug release, showing significant anticancer effects on melanoma cells in vivo.

PHARMACEUTICS (2022)

Review Biochemistry & Molecular Biology

Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics

Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik

Summary: CBD, a marijuana derivative, has a long history of medical use and is increasingly recognized for its potential anti-tumor properties. Besides its direct anti-cancer effects, CBD and other cannabinoids have shown promise in attenuating chemotherapy-induced adverse effects and enhancing the efficacy of anti-cancer drugs. However, CBD's interactions with other medications and therapeutic modalities can be unpredictable, raising concerns about its combined use. This review summarizes the current knowledge of CBD's interactions with selected anticancer chemotherapeutics, discusses the potential benefits and risks, and highlights the need for clinical trials to evaluate the impact of CBD combinations in oncology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

An efficient, non-invasive approach for in-vivo sampling of hair follicles: design and applications in monitoring DNA damage and aging

Natalie Kudlova, Hanus Slavik, Pavlina Duskova, Tomas Furst, Josef Srovnal, Jiri Bartek, Martin Mistrik, Marian Hajduch

Summary: The study has developed a new method for sampling and analyzing animal hair follicles, which can replace stressful and painful biopsies. The main components of hair follicles, live cells of epithelial origin, are highly relevant for most types of malignant tumors, providing opportunities for studying aging-related pathologies such as cancer.

AGING-US (2021)

No Data Available